189 related articles for article (PubMed ID: 28527208)
1. Neuronal Expression of Truncated Tau Efficiently Promotes Neurodegeneration in Animal Models: Pitfalls of Toxic Oligomer Analysis.
Skrabana R; Kovacech B; Filipcik P; Zilka N; Jadhav S; Smolek T; Kontsekova E; Novak M
J Alzheimers Dis; 2017; 58(4):1017-1025. PubMed ID: 28527208
[TBL] [Abstract][Full Text] [Related]
2. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
3. Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases.
Nilson AN; English KC; Gerson JE; Barton Whittle T; Nicolas Crain C; Xue J; Sengupta U; Castillo-Carranza DL; Zhang W; Gupta P; Kayed R
J Alzheimers Dis; 2017; 55(3):1083-1099. PubMed ID: 27716675
[TBL] [Abstract][Full Text] [Related]
4. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
[TBL] [Abstract][Full Text] [Related]
5. Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells.
Usenovic M; Niroomand S; Drolet RE; Yao L; Gaspar RC; Hatcher NG; Schachter J; Renger JJ; Parmentier-Batteur S
J Neurosci; 2015 Oct; 35(42):14234-50. PubMed ID: 26490863
[TBL] [Abstract][Full Text] [Related]
6. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
[TBL] [Abstract][Full Text] [Related]
7. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
[TBL] [Abstract][Full Text] [Related]
8. Tauopathies and tau oligomers.
Takashima A
J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
[TBL] [Abstract][Full Text] [Related]
9. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau.
Tanemura K; Murayama M; Akagi T; Hashikawa T; Tominaga T; Ichikawa M; Yamaguchi H; Takashima A
J Neurosci; 2002 Jan; 22(1):133-41. PubMed ID: 11756496
[TBL] [Abstract][Full Text] [Related]
10. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
[TBL] [Abstract][Full Text] [Related]
11. Brief update on different roles of tau in neurodegeneration.
Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
[TBL] [Abstract][Full Text] [Related]
12. Expression of a truncated human tau protein induces aqueous-phase free radicals in a rat model of tauopathy: implications for targeted antioxidative therapy.
Cente M; Filipcik P; Mandakova S; Zilka N; Krajciova G; Novak M
J Alzheimers Dis; 2009; 17(4):913-20. PubMed ID: 19542619
[TBL] [Abstract][Full Text] [Related]
13. Tau Protein and Zebrafish Models for Tau-Induced Neurodegeneration.
Ding Y; Lei L; Lai C; Tang Z
J Alzheimers Dis; 2019; 69(2):339-353. PubMed ID: 31006683
[TBL] [Abstract][Full Text] [Related]
14. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
15. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
Cente M; Filipcik P; Pevalova M; Novak M
Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
[TBL] [Abstract][Full Text] [Related]
16. Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo.
Violet M; Chauderlier A; Delattre L; Tardivel M; Chouala MS; Sultan A; Marciniak E; Humez S; Binder L; Kayed R; Lefebvre B; Bonnefoy E; Buée L; Galas MC
Neurobiol Dis; 2015 Oct; 82():540-551. PubMed ID: 26385829
[TBL] [Abstract][Full Text] [Related]
17. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration.
Galán-Ganga M; Rodríguez-Cueto C; Merchán-Rubira J; Hernández F; Ávila J; Posada-Ayala M; Lanciego JL; Luengo E; Lopez MG; Rábano A; Fernández-Ruiz J; Lastres-Becker I
Acta Neuropathol Commun; 2021 May; 9(1):90. PubMed ID: 34001284
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization.
Shirafuji N; Hamano T; Yen SH; Kanaan NM; Yoshida H; Hayashi K; Ikawa M; Yamamura O; Kuriyama M; Nakamoto Y
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562600
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
